Table 2.
Gender | FOXP3 haplotype (-2383 C/T, IVS9+459 T/C) | Lung cancer patients n (%) | Control group n (%) | P-value |
---|---|---|---|---|
Male (n=126) | CT | 68 (54.0) | 63 (50.0) | 0.17 |
TT | 15 (11.9) | 8 (6.3) | ||
CC | 42 (33.3) | 55 (43.7) | ||
TC | 1 (0.8) | 0.0 | ||
Female (2n=60) | CT | 38 (63.3) | 36 (60.0) | 0.42 |
TT | 6 (10.0) | 3 (5.0) | ||
CC | 16 (26.7) | 21 (35.0) | ||
TC | 0.0 | 0.0 |